Label Changes for:
Zometa (zoledronic acid for injection)
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – February 2011
- ...pyrexia, asthenia, fatigue, or malaise persisting for greater than 30 days has been observed